EyePoint Pharmaceuticals Inc. buy Capital One Financial Co.
Start price
11.12.23
/
50%
€18.40
Target price
11.12.24
€40.94
Performance (%)
-40.87%
Price
17.05.24
€10.88
Summary
This prediction is currently active. The BUY prediction by Capital_One_Financia for EyePoint Pharmaceuticals Inc. is performing very badly with a performance of -40.87%. This prediction currently runs until 11.12.24. The prediction end date can be changed by Capital_One_Financia at any time. Capital_One_Financia has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
EyePoint Pharmaceuticals Inc. | -3.972% | -3.972% |
iShares Core DAX® | -0.268% | 5.471% |
iShares Nasdaq 100 | 1.854% | 7.851% |
iShares Nikkei 225® | 0.284% | 1.729% |
iShares S&P 500 | 1.178% | 5.269% |
Comments by Capital_One_Financia for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $44.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat